Osteoarthritis
Conference Coverage
Experts review the year in rheumatology ... and what lies ahead
Thought leaders pick rheumatology’s top developments in the past year and predict the big events to come at the Rheumatology Winter Clinical...
From the Journals
Turmeric-, frankincense-derived supplement shows OA benefit
The combination beat placebo in a randomized, controlled trial from Armenia.
From the Journals
Arthritis treatment costs per person held steady from 2008 to 2014
But why did it cost $60 billion more in aggregate treatment costs in 2014?
Conference Coverage
Sprifermin shows cartilage-building potential in knee OA patients
Interim results indicate that sprifermin could be the first investigational medicinal product to show a dose-dependent increase in cartilage...
Conference Coverage
Evidence builds for long-term ineffectiveness of steroid shots for knee OA
SAN DIEGO – Injections may actually boost the risk that condition will worsen
News
FDA recommends voluntary recall of Limbrel
“Health care providers who are aware that their patients are taking Limbrel should advise them to immediately stop taking the product,” the FDA...
From the Journals
Arthritis prevalence higher than previously thought, especially in adults under 65
Two additional survey questions greatly improved sensitivity for arthritis.
Conference Coverage
Injectable agent found to improve knee function in OA patients
SAN DIEGO – There were no measurable between-knee differences in cartilage thickness or volume but statistically significant and clinically...
News
FDA approves first extended-release steroid injection for OA knee pain
The microsphere-based formulation is intended to prolong the release of triamcinolone acetonide inside the synovial fluid.
Conference Coverage
Dr. Clyde Yancy: CANTOS wows, opens new therapeutic avenues
BARCELONA – Inflammatory pathway for cardiovascular disease and lung cancer found in groundbreaking trial paves way for personalized medicine.
Conference Coverage
VIDEO: Prescription-strength ibuprofen worsens blood pressure more than other NSAIDs
BARCELONA – Celecoxib performs best in PRECISION-ABPM trial.